Genomic Biotech Peer Comparison

BSE: 539206

₹50.50

₹2.40 (4.99%)

As on 02-Nov-2026 12:36IST

Market cap

₹15 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

3.7

Div. Yield

0 %

Edit

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Market cap (₹ Cr)	15	278	15,185	8,073	564
Revenue (₹ Cr)	0	145	4,131	979	388
Net Profit (₹ Cr)	--	-4.90	411.10	279.70	35.56
Net Margin (%)	-0.79	-3.31	9.78	27.97	8.59
RoE (%)	-0.03	-4.53	13.13	76.43	6.94
Price to Earnings	--	--	36.94	28.86	15.83
Price-To-Book	3.74	2.91	4.52	19.02	1.28

Income Statement (₹ Cr)

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Operating Revenue	0.84	138.50	2,839.30	878.40	326.67
Total Income	0.85	140.73	2,946.50	896.80	335.94
Total Expenditure	0.40	120.56	2,305.00	569.40	287.90
EBITDA	0.44	17.94	534.30	309.00	38.77
Depreciation	0.00	6.77	80.20	11.70	2.61
EBIT	0.44	11.17	454.10	297.30	36.16
Interest	0.00	2.27	22.00	2.00	3.17
Other Income	0.00	2.23	107.20	18.40	9.27
Exceptional Items	--	-0.41	2.40	6.60	17.85
Profit before Tax	0.44	11.12	539.30	320.30	60.43
Provision for Tax	0.09	3.19	132.60	80.20	13.98
Profit after Tax	0.36	7.93	406.70	240.10	46.45

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Shareholder's Funds	3.90	104.74	2,615.60	384.00	173.11
Minority Interest	--	-1.16	--	--	0.00
Non-Current Liabilities	0.00	25.99	56.00	229.90	25.54
Current Liabilities	0.46	46.63	564.50	128.40	225.47
Total Liabilities	4.36	176.20	3,325.90	750.80	426.56

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Non-Current Assets	1.73	108.77	706.10	248.00	110.26
Current Assets	2.62	67.43	2,530.00	494.30	308.24
Total Assets	4.36	176.20	3,325.90	750.80	426.56
Total Debt*	0.00	38.00	0.00	0.00	54.62
Net Current Assets	2.16	20.80	1,965.50	365.90	82.76
Contingent Liabilities	--	26.88	0.70	1.50	32.56

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Cash From Operating Activities	0.03	1.90	441.90	174.80	-36.14
Cash Flow from Investing Activities	0.01	-11.80	-682.70	7.60	-20.05
Cash from Financing Activities	--	5.29	287.50	-134.50	36.26
Net Cash Inflow / Outflow	0.04	-4.60	46.70	47.90	-19.94

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
ROCE (%)	11.87	10.01	25.24	98.11	34.43
ROE (%)	9.57	9.71	20.45	73.20	30.46
ROA (%)	8.20	4.76	14.24	37.26	13.43
EBIT Margin (%)	52.63	14.56	22.59	37.27	14.71
Net Margin (%)	41.97	5.64	13.80	26.77	13.83
Cash Profit Margin (%)	42.50	10.62	17.15	27.35	15.02

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Revenue Growth (%)	411.25	24.55	9.64	21.24	44.46
EBIT Growth (%)	2,529.91	17.46	10.28	15.44	22.22
Net Profit Growth (%)	2,245.51	402.74	20.79	32.65	70.67
EPS Growth (%)	2,245.67	398.40	11.96	32.65	70.68
Book Value Growth (%)	10.05	76.48	84.55	41.18	31.26

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Price / Earnings	50.26	44.97	34.05	43.36	0.00
Price / Book Value	4.59	3.46	5.37	27.11	0.00
Dividend Yield (%)	0.00	0.00	0.35	1.66	--
EV/EBITDA	40.19	19.68	21.00	30.65	1.08
Market Cap (₹ Cr)	17.90	360.30	13,848.97	10,410.62	0.00

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Debt to Equity	0.00	0.36	0.00	0.00	0.32
Short term debt to equity ratio	--	0.14	0.01	--	0.31
Current Ratio	5.73	1.45	4.48	3.85	1.37
Quick Ratio	5.11	1.18	4.48	3.37	1.10
Interest Coverage	2,845.31	5.90	25.51	161.15	20.04

	Genomic Biotech	Lyka Labs	Indegene	Sanofi Consumer Healthcare India	Fabtech Technologies
Debtors to sales (%)	262.40	31.10	26.46	3.37	46.14
Asset Turnover	0.19	0.83	0.99	1.43	0.94
Receivable days	1,026.01	92.33	89.95	8.58	138.21
Inventory Days	122.93	29.04	0.00	20.38	49.55
Payable days	554.30	88.82	--	118.89	164.44
Cash Conversion Cycle	594.64	32.55	--	-89.93	23.32

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.